Peter Fernandes

Peter Fernandes

Company: Bellerophon Therapeutics

Job title: Chief Executive Officer


Adapting Clinical Trial Design & Endpoints for ILD Therapeutic Development: Harnessing Digital Health Technology (DHT) Endpoints 9:00 am

Selecting and expanding the ILD patient population Adapting clinical trials using digital health technology to facilitate remote monitoring of patients health status Incorporating the patient perspective into clinical trial design Assessing digital endpoints across fibrotic ILDs studiesRead more

day: Day Two

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.